STOCK TITAN

Stewards updates resale of up to 20.6M shares

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
424B3

Rhea-AI Filing Summary

Stewards, Inc. (SWRD) updated a resale prospectus covering up to 20,621,250 shares of common stock for sale by selling stockholders. The shares include 9,750,000 issued in the private placement, 487,500 issued as a registration delay payment, and 10,383,750 issuable upon exercise of warrants and pre-funded warrants. The covered shares exclude shares issued in the Envy Pompano Beach acquisition and shares issued or issuable in connection with the convertible note offering.

After SWRD began trading on the Nasdaq Capital Market on September 10, 2026, the prior $3.00 fixed-price limitation no longer applies; selling stockholders may sell at prevailing market prices, prices related to prevailing market prices, or negotiated prices. Stewards will not receive proceeds from resale sales, but may receive cash proceeds if warrants or pre-funded warrants are exercised for cash. An active, liquid trading market may not develop or be sustained.

Shares covered for resale Up to 20,621,250 shares Common stock offered for resale by the selling stockholders named in the prospectus.
Private placement shares issued 9,750,000 shares Included in the shares covered for resale.
Registration delay payment shares 487,500 shares Issued as a registration delay payment and included in the shares covered for resale.
Shares issuable upon warrant exercise 10,383,750 shares Shares issuable upon exercise of warrants and pre-funded warrants included in the resale prospectus.
Fixed-price limitation $3.00 per share Applied to sales while the common stock was quoted on the OTCID Market; the limitation no longer applies after Nasdaq trading began.
pre-funded warrants technical
"exercise of warrants and pre-funded warrants"
Pre-funded warrants are financial instruments that give investors the right to purchase a company's stock at a set price, but with most or all of the purchase price paid upfront. They function like a coupon or gift card for stock, allowing investors to buy shares later at a fixed price, which can be beneficial if they want to avoid future price increases. This makes them important for investors seeking flexibility and certainty in their investment plans.
registration delay payment financial
"shares issued as a registration delay payment"
fixed-price limitation financial
"the $3.00 fixed-price limitation described in the Prospectus"
Offering Type secondary
Securities Offered Common stock
Offering Amount Up to 20,621,250 shares
Use of Proceeds Stewards will not receive proceeds from sales by the selling stockholders; it may receive proceeds from cash exercises of warrants and pre-funded warrants.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many SWRD shares are covered for resale?

The resale prospectus covers up to 20,621,250 shares of Stewards common stock. This includes 9,750,000 shares issued in the private placement, 487,500 issued as a registration delay payment, and 10,383,750 issuable upon exercise of warrants and pre-funded warrants.

Does Stewards receive proceeds from the SWRD resale?

Stewards will not receive proceeds from sales by the selling stockholders. The company may receive proceeds if warrants or pre-funded warrants are exercised for cash.

How may selling stockholders price SWRD shares under the resale prospectus?

Selling stockholders may sell at prevailing market prices, prices related to prevailing market prices, or negotiated prices. The $3.00 fixed-price limitation no longer applies after trading began on the Nasdaq Capital Market on September 10, 2026; sales while the stock was quoted on the OTCID Market remained subject to that limit.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

 
Filed pursuant to Rule 424(b)(3)
Registration Statement No. 333-291586

Prospectus Supplement No. 11
(To prospectus dated July 16, 2026)
image_0.jpg
20,621,250 Shares of Common Stock

This Prospectus Supplement No. 11 (this “Prospectus Supplement”) supplements the prospectus dated July 16, 2026 (the “Prospectus”) relating to the resale of up to 20,621,250 shares of common stock, par value $0.0001 per share, of Stewards, Inc. (formerly known as Favo Capital, Inc.) (the “Company,” “we,” “us,” or “our”) by the selling stockholders named in the Prospectus. These shares were issued to the selling stockholders pursuant to a Securities Purchase Agreement in connection with a private placement that closed on December 12, 2024 and July 30, 2025. The shares include 9,750,000 shares of common stock issued in the private placement, an additional 487,500 shares issued as a registration delay payment, and 10,383,750 shares issuable upon the exercise of warrants and pre-funded warrants issued in the same private placement. The shares covered by the Prospectus do not include the shares issued in the Envy Pompano Beach acquisition or any shares issued or issuable in connection with the convertible note offering described in prior Form 8-K filings.

This Prospectus Supplement is being filed to update and supplement the information in the Prospectus with the information contained in the Company’s Current Report on Form 8-K filed on November 12, 2026 (date of earliest event reported: November 11, 2026) and the Company’s Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2026, filed on November 16, 2026. The text of the Form 8-K is attached hereto as Exhibit 99.1 and the text of the Form 10-Q is attached hereto as Exhibit 99.2.

Plan of Distribution; Offering Price

As previously disclosed in Prospectus Supplement Nos. 5 through 10, the Company’s common stock commenced trading on the Nasdaq Capital Market under the symbol “SWRD” at the market open on September 10, 2026, and quotation on the OTCID Market ceased at the close of trading on September 9, 2026. Accordingly, the $3.00 fixed-price limitation described in the Prospectus no longer applies.

The selling stockholders may sell the shares covered by the Prospectus from time to time on the Nasdaq Capital Market or otherwise at prevailing market prices at the time of sale, at prices related to prevailing market prices, or at negotiated prices, in the manner described under “Plan of Distribution” in the Prospectus. Any sales under the Prospectus that occurred while the common stock was quoted on the OTCID Market remained subject to the $3.00 fixed price.

We will not receive any proceeds from sales of shares by the selling stockholders. We may receive proceeds from the exercise of the warrants and pre-funded warrants if exercised for cash.

Our common stock trades on the Nasdaq Capital Market under the symbol “SWRD.” An active, liquid trading market may not develop or be sustained.

This Prospectus Supplement should be read in conjunction with the Prospectus and Prospectus Supplement Nos. 1 through 10, which are to be delivered with this Prospectus Supplement. This Prospectus Supplement is qualified by reference to the Prospectus and prior supplements, except to the extent the information herein updates or supersedes that information.




NEITHER THE SECURITIES AND EXCHANGE COMMISSION NOR ANY STATE SECURITIES COMMISSION HAS APPROVED OR DISAPPROVED OF THESE SECURITIES OR PASSED UPON THE ACCURACY OR ADEQUACY OF THIS PROSPECTUS SUPPLEMENT OR THE PROSPECTUS. ANY REPRESENTATION TO THE CONTRARY IS A CRIMINAL OFFENSE.

The date of this Prospectus Supplement is November 17, 2026





Keep reading